Drugs and Polypharmacy Flashcards

1
Q

Define polypharmacy

A

Use of 5+ medications but unnecessary medication

Which can place an older person at risk of avoidable toxic reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many different drugs do you need to take before there is a guaranteed ADR?

A

9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What % of ADRs are preventable?

A

1/3rd in ambulatory settings

1/2 in nursing homes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some costly medication related problems/ARDs in older patients?

A
Falls
Cognitive loss/dementia
Dehydration 
Incontinence
Depression 

Leading to loss of functional capability, reduced QoL, nursing home placement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the typical drug consumption of a 85yo?

A

8-9 prescribed drugs

2 OTC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why are elderly patients taking more drugs?

A

More acute and chronic disease
More doctor visits (may see diff doctors each time –> more and more drugs)
Drugs given to counteract SEs of other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some ARD symptoms that may just get labelled as ‘getting old’?

A
Unsteadiness
Dizziness
Confusion 
Nervousness
Fatigue
Insomnia
Drowsiness
Falls
Depression 
Incontinence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the ‘prescribing cascade’ that often happens in the pharmacological management of an elderly patient

A

Drug 1 give, ADE interpreted as new medical condition, so drug 2 given and so on

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is stated in the SIGN guideline 116 for management of diabetes?

A
Aim for HbA1c <7% or individualised
BP <130/80
ACEi>ARB>CCB>thiazide
Avoid alpha and beta blockers
Statins if <40
Aspirin for secondary prevention only
Lifestyle advice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the problem with the sign 116 guidelines in elderly patients?

A

Very strict targets
If multimorbid will be very difficult to reach targets
Not much evidence that really tight glycaemic control is beneficial in elderly (only beneficial if started mid-life and long term)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Apart from diabetes, what other condition shows loss of benefit for tight control in geriatric populations?

A

HTN (tight BP control may be dangerous in these groups)

Beneficial only for those able to walk, for those unable if was detrimental to give anti-hypertensives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the problems with guidelines for those who are multi-morbid?

A

There are many guidelines for each individual condition but none to fit all of their conditions

Cross-referenced NICE guidelines for T2DM, depression, heart failure and 11 other specific diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are elderly patients medicines meant to be checked?

A

All >75y meant to have annual medication review

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some healthcare provider factors that contribute to polypharmacy?

A

No med review
Presumes patient expects meds
Prescribes without sufficient Ix
Evidence that a particular drug is best for a problem
Complications of many problems and multiple providers
Unclear, complex or incomplete instructions on how to take meds
No effort to simplify med regimen
Ordering automatic refills
Medications promoted and publication bias
Lack of knowledge of geriatric clinical pharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does absorption differ in older people?

A

Rate of absorption affected but not extent of absorption from GIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give an example of how absorption may differ in an older person

A

GTN
Delayed absorption due to changed physiology & reduced saliva production, so patient may take more drug than they need –> BP falls –> vasovagal syncope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the exception to the rule for how absorption differs in the elderly?

A

Levodopa
There is substantial mucosal metabolism of this by dopa-decarboxylase enzyme
Reduced dopa-decarboxylase as this is secreted in saliva and there is reduced saliva production
So increased absorption and higher peak level quicker than younger patients

18
Q

What body compositional changes in elderly patients mean they have different distribution of drugs?

A

Reduced muscle mass and water content
Increased fat content

Particularly significant if drug highly lipid soluble, widely distributed into muscle/contained in water

19
Q

How will the distribution of fat soluble drugs difer in an elderly patient?

A

Vd increased due to increased body fat

(e.g. fat soluble drugs - haloperidol, diazepam)

Adipose tissue acts as a reverse for these drugs, so enhanced t1/2

20
Q

How will the distribution of fat soluble drugs differ in an elderly patient?

A

Tend to reduce Vd –> higher serum levels

E.g. of water soluble drugs - digoxin, theophylline, atenolol, propranolol, hydrochlorothiazide

21
Q

How does protein binding differ in elderly patients?

A

Total serum albumin decreases by 12%
So more unbound, free drug
Common diseases in elderly depress albumin (HF, renal dx, RA, hepatic cirrhosis, some malignancies)

22
Q

Give examples of protein bound drugs

A

Furosemide, diazepam, cimetidine, propanolol

23
Q

How is the blood brain barrier affected by age?

A

More permeable so drug more easily distributed to CNS

24
Q

Why must you be careful in dosing digoxin in the elderly?

A

Reduction of muscle mass means there is a significant reduction in digoxins Vd so loading dose must be substantially reduced

25
How is hepatic metabolism in the elderly differ?
Decreased liver mass and decreased liver blood flow
26
What are the consequences of reduced metabolism in the elderly?
Toxicity due to reduced metabolism/excretion Reduced first pass metabolism (increased bioavailability of some drugs, e.g. propranolol and reduced bioavailability of pro-drugs, e.g. enalapril)
27
How is excretion affected by increased age?
Renal function decreases with age Reduced clearance --> increased t1/2 --> increased toxicity Consider elderly patients to have some renal function as young person with CKD
28
Elderly patients have decreased/increased sensitivity to particular medicines. Why is this?
Increased Due to changes in receptor binding, decrease in receptor number, altered translation of receptor iniaited cellular response into a biochemical reaction
29
What medications are elderly people more sensitive to?
Diazepam | Warfarin
30
What are the worst drugs to give elderly patients?
Anticholingerics | Sedatives
31
Give examples of anticholingerics
``` Oxybutinin TCAs Antiemetics Antipsychotics Ranitidine, phenytoin, digoxin, fluoxetine, lithium ```
32
What can you use to assess the risk of giving an elderly patient an anticholingeric?
Anticholingeric burden scale
33
Finish the sentence: | The more anticholingeric burden you have, the more likely you are to...
Develop symptoms, have poorer outcomes, develop dementia etc.
34
What are the principles for prescribing for older people?
Ensure clear diagnosis Consider if drug therapy the best option Lower doses/reduced frequency generally needed Think about particular problems with that drug in the elderly Review new drug and check if achieving its aim Address compliance issues (e.g. dispending aids)
35
Where can you find drug information for elderly patients?
BNF | Schedule of product characteristics
36
What are usual prescribing tools to help you in geriatrics?
Beer's criteria (list of inappropriate drugs for older people) STOPP-START criteria (advice on medical optimisation) NHS polypharmacy guidance
37
What does the NHS polypharmacy guidance look at?
``` Aims of drug Rx Need Effectiveness Safety Cost effectiveness Adherence/patient centeredness ```
38
What is deprescribing?
To reduce, substitute or discontinue a drug
39
Why might you deprescribe?
``` ADRs DDIs Better alternative Not effective Not indicated Not evidence based Minimise polypharmacy (proactive deprescribing) ```
40
What are the benefits for proactive deprescribing?
Drops mortality and admission to care homes
41
How is deprescribing done locally?
When GPs do their annual >75 reviews, they meet with geriatricians and pharmacists to reduce polypharmacy Target high risk groups, e.g. care homes